Herbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling Shift

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), provides an update on recent regulatory developments in the United States relating to the proposed rescheduling of cannabis under the Controlled Substances Act. The U.S. Department of Health and Human Services has recommended that cannabis be reclassified from Schedule I to Schedule III, a move that, if finalized by the Drug Enforcement Administration, would represent a transformational shift for the U.S. cannabis industry and a major catalyst for capital inflows, institutional participation, and sector re-rating.